Home / Meet the Worldwide Leadership Team

Meet the Worldwide Team

Worldwide Clinical Trials started out more than 30 years ago as a small science team with a big goal: To always provide authentic, personalized attention to our partners. And as the industry has grown, CROs have merged, and trials have grown increasingly complex, we haven’t forgotten what truly matters: People.

With more than 3,000 employees in more than 60 countries around the world, we’re still staying true to those roots. Our team is dedicated to staying accessible, flexible, and solution-focused to ensure our partners not only have the best possible outcomes – but they also know their Worldwide team is only a call away.

Explore more about our team below.

  • Leadership
  • Sales
  • Therapeutic Experts
    • Cardiovascular
    • General Medicine
    • Neuroscience
    • Oncology
    • Rare Disease
    • Endocrine & Metabolic
    • Cell & Gene Therapy
  • Solutions
    • Pre IND & Phase I
    • Phase II-III
    • Phase IV & Real World Evidence
    • Biosimilars
    • Regulatory

Sherilyn Adcock, RPh, PhD

Chief Scientific Officer, Early Phase Development

Jeff Almrud, PhD

Senior Director, Project Management

Sarah Rose Anderson

Executive Director, Oncology, Therapeutic Strategy Lead, Business Development

Derek Ansel

Executive Director, Therapeutic Strategy Lead, Rare Diseases

Tamara Ast, PhD

Executive Vice President, Global Therapeutic Lead, Neuroscience

Rolana Avrumson, MS

Vice President of Clinical Projects, Clinical Assessment Technologies

Tom Babic, MD, PhD

Vice President, Scientific Solutions, Neuroscience

Scott Beasley

Executive Director, Project Management, NASH

Richard Bennett

Senior Director, Therapeutic Strategy Lead, Neuroscience

Lucy Bennett

Executive Director, Project Management

Peter Benton, MBA

President and Co-CEO

Peter Böhm

Senior Director Project Management, Neuroscience – Spain

David Bowser, MBA

Executive Vice President and Chief Operating Officer

Jake Boyd

Director, Project Management

Emmet Browne

Vice President, Commercial EU

Mireille Cantarini, BSc, MB, ChB, MRCP, FFPM

Senior Medical Director, Medical Affairs, Oncology

Angelico Carta, MD

President

Idil Cavus, MD, PhD

Vice President, Central Nervous System Therapeutic Area Lead, Medical Affairs

Giovanna Morley

Vice President, BD Americas

Cheryl Chapman

Executive Director, Project Management, Oncology

Steve Chriscoe

Vice President, Project Management, Oncology

Joy Clark

Chief People Officer

Stephen Coates

Executive Director, Project Management, Alzheimer’s Disease and other Dementias

Stefan Comhaire

Executive Director, Project Management

Matt Cooper, PhD

Executive Director, Therapeutic Strategy Lead, Oncology

Rosemarie Corrigan, FRQA, FRSB

Executive Vice President, Global Quality

Martin Cummins

Executive Director, Project Management

Neal Cutler, MD

Founder & Chief Executive Officer

Sara Davis

Executive Vice President and Chief Commercial Officer

Craig Dorer-Abadia

Senior Director, Project Management, Oncology

Natalia Drosopoulou, PhD

Vice President, Project Management, Neuroscience

Pete Duprat

Senior Vice President, Commercial, Early Phase

Dana F. Durst

Senior Director, Site Activation & Regulatory Therapeutic Lead, Oncology

Barry Dussault

Executive Director, Project Management, Franchise Area Lead, Analgesia, Addiction, and Neurology Rare Disorders

Jim Eamma

Senior Director, Project Management, Oncology & Hematology

Haytham Elgammal, MD, PMBA

Medical Director, General Medicine & Rare Diseases

Leimin (Perry) Fan

Associate Director, Method Development

Ted Finlan

Senior Vice President, Project Planning & Administration

Gary Fishbein, MD, MPH

Vice President, Therapeutic Area Lead, Oncology

Julia Forte

Senior Director, Project Management

Andre Ganem

Senior Vice President, Global Site Management

Virgilio Garcia Lerma

Senior Director, Regulatory Pre-Award Strategy

Jason Hamilton, PhD

Associate Director, Method Validation

Karen Hill

President of CVM, Inflammatory Diseases, & Evidence Business Units

Monika Iten, PhD

Vice President Project Management, Cardiovascular

Bartosz Janikowski, MD

Senior Vice President, Medical Sciences

Aman Khera

Global Head of Regulatory Strategy

Ariela Knallevsky, MD

Senior Medical Director, Medical Affairs

Richard Koenig

Executive Director, Project Management, Psychiatry and Neuroscience Rare Diseases

Olga Kolotilina, MD

Senior Medical Director, Medical Affairs

Peter Lammers

Executive Vice President of Marketing and Commercial Operations

peter-lammers-evp-marketing

Barry Lederman

Chief Financial Officer

Lisa Leuzzi

Vice President, Project Management, Psychiatry and Neurology

Drew Matheson

Executive Director. Franchise Area Lead Respiratory Medicine and Infectious Disease

Mike Mencer

Executive Vice President and General Manager, Early Phase

Juliane K. Mills, MS, MPH

Therapeutic Strategy Lead, Rare Disease

Christine Moore, PhD

Vice President, Neuroscience, Scientific Solutions

Anne-Claude Muratet

Executive Director, Project Management, Neurology and Rare Diseases

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer

Gerardo Pascuali

Executive Director, Regional Clinical Operations, Latin America

Paula Penney

Executive Director, Project Management, Alzheimer’s Disease and other Dementias

Daniel A. Perez, CCRP

Director & Global Head of Patient Experience, Diversity & Inclusion

Vladimir Radovic, MD

Senior Medical Director, Medical Affairs

Amy Raymond, PhD, PMP

Senior Director, Therapeutic Strategy Lead, Rare Diseases & Cellular and Genetic Medicines

Joanna Reeder

Vice President, Project Management, Other and Rare Diseases

Henry J. Riordan, PhD

Chief Development Officer

Seth Schulman, MD

Senior Medical Director

Lona Sheeran

Senior Vice President, Clinical Operations Early Phase

Marie T. Simerly, PMP

Senior Director, Project Management Early Phase

Jeffrey G. Stark, Ph.D.

Senior Director, Head of Pharmacokinetics

Attila Timar-Peregrin, MD, PhD

Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases

Jeff Trotter, MBA

Senior Vice President, Scientific Solutions, Real-World Evidence

Eteri Tsetskhladze, MD, PhD, FESC, FACC

Vice President, General Medicine Medical Lead, Medical Affairs

Mary Glenn Vreeland

Senior Director, Real-World Evidence

Clare Wallis

President of Oncology Business Unit

Tom Zhang, PhD.

Chief Scientific Officer, Large Molecule Bioanalysis

Rafal Ziecina, MD, PhD

Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic

See what Worldwide Clinical Trials can do for you.

Fill out the brief form to get in touch.